Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy
We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated DOX onto the periphery of partially acetylated and...
Main Authors: | Mengen Zhang, Jingyi Zhu, Yun Zheng, Rui Guo, Shige Wang, Serge Mignani, Anne-Marie Caminade, Jean-Pierre Majoral, Xiangyang Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/10/3/162 |
Similar Items
-
SYNTHESIS AND CHARACTERIZATION OF DOXORUBICIN CARRYING CETUXIMAB-PAMAM DENDRIMER BIOCONJUGATES
by: SAXENA, GUNJAN
Published: (2012) -
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
by: Monika Marcinkowska, et al.
Published: (2018-02-01) -
High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers
by: Karla I. Garfias-Gonzalez, et al.
Published: (2015-05-01) -
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
by: Mohammad Najlah, et al.
Published: (2017-10-01) -
Nanoparticle Effects on Human Platelets in Vitro: A Comparison between PAMAM and Triazine Dendrimers
by: Alan E. Enciso, et al.
Published: (2016-03-01)